PATENT CLAIM ANALYSIS

Application Number: 16211743
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-10
Patent Classification: ["424", "093450"]

Abstract:
This invention relates to new uses of  Bifidobacteria  (particularly, although not exclusively, probiotic  Bifidobacteria ), and to food products, feed products, dietary supplements and pharmaceutical formulations containing them. The bacteria are suitable for the treatment of diabetes (particularly Type 2 diabetes), obesity and related conditions, metabolic syndrome, insulin resistance, and impaired glucose metabolism and consequences thereof, lowering tissue inflammation, treating hepatitis, myositis and cardiovascular conditions.

Claim (Index 45):
A method of treating a disease or condition in a mammal, wherein:\n the method comprises administering to a mammal in need of such treatment a combination of (i) a bacterium of the genus  Bifidobacterium  and (ii) an antidiabetic drug; and the disease or condition is selected from:\n (a) diabetes; \n (b) metabolic syndrome; \n (c) impaired glucose tolerance; \n (d) reduced insulin sensitivity; \n (e) reduced fed insulin secretion; \n (f) elevated fasted insulin secretion; \n (g) obesity; \n (h) weight gain; \n (i) elevated body fat mass; and \n (j) elevated mesenteric fat mass.

Metadata:
- Claim Count in Document: 104.0
- Percentile: 98.0
- Lexical Diversity: 1.46429
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13384748', '14983827', '15744211', '14457916', '15565317']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7917688481945038
- 35 USC 102 Novelty (BERT): 0.583453950894361
- Combined Prediction Score: 0.7709373584644895
- Mean Citation Score: 413.4368759999999
- Max Citation Score: 519.724
- Similarity Product: 408.2619384641648

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test